ArticleJournal of surgical case reports2026
Retiform hemangioendothelioma of the breast: a case report and considerations for effective management.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retiform hemangioendothelioma (RHE) is a rare vascular neoplasm of intermediate malignancy, with a high frequency of local recurrence and negligible metastasizing potential. We describe a 45-year-old female who presented with a firm subcutaneous nodule in the lower-outer quadrant of the right breast. Diagnosis of RHE was confirmed based on the characteristic retiform pattern of the branching neoplastic vascular channels, as well as positivity for CD31 and negativity for D2-40 markers. The patient was successfully treated with wide local excision of the tumor with clear surgical margins. The resulting defect was reconstructed with local tissue displacement and direct closure. RHE must be considered in the differential diagnosis of skin vascular tumors, while histopathological and immunohistochemical examination remain core to the diagnosis. Wide local excision with clear margins is the treatment of choice, whereas radiotherapy and, more rarely, chemotherapy can be considered in the event of recurrence and in unresectable cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.